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Abstract 
Background. Enteric protozoa are associated with diarrhoeal illness-
es in humans; however there are no recent studies on their epidemi-
ology and geographical distribution in Australia. This study describes
the epidemiology of enteric protozoa in the state of New South Wales
and incorporates spatial analysis to describe their distribution. 
Design and methods. Laboratory and clinical records from four pub-
lic hospitals in Sydney for 910 patients, who tested positive for enteric
protozoa over the period January 2007 - December 2010, were identi-
fied, examined and analysed. We selected 580 cases which had resi-
dence post code data available, enabling us to examine the geograph-
ic distribution of patients, and reviewed the clinical data of 252
patients to examine possible links between protozoa, demographic and
clinical features. 
Results. Frequently detected protozoa were Blastocystis spp. (57%),
Giardia intestinalis (27%) and Dientamoeba fragilis (12%). The age
distribution showed that the prevalence of protozoa decreased with
age up to 24 years but increasing with age from 25 years onwards. The
geographic provenance of the patients indicates that the majority of
cases of Blastocystis (53.1%) are clustered in and around the Sydney
City Business District, while pockets of giardiasis were identified in
regional/rural areas. The distribution of cases suggests higher risk of
protozoan infection may exist for some communities. 
Conclusions. These findings provide useful information for policy
makers to design and tailor interventions to target high risk commu-
nities. Follow-up investigation into the risk factors for giardiasis in
regional/rural areas is needed.
Introduction 
Several species of enteric protozoa are associated with diarrhoeal
illnesses in humans. Some cause severe debilitating conditions in
immunosuppressed and immune-competent populations.1 Protozoan
related morbidity and mortality in humans worldwide is well docu-
mented. However, little attention has been paid to human infections in
developed countries, where the risk of transmission is presumed to be
low.2 Focus is usually placed on opportunistic infections with protozoa
such as Cryptosporidium spp., Cyclospora cayetanensis and
Cystoisospora beli, implicated in prolonged diarrhoea in immunosup-
pressed patients, such as those with HIV/AIDS, compensated idiopath-
ic hepatic cirrhosis, protein energy malnutrition, and Hodgkin’s lym-
phoma.3,4 However, in addition to others such as Giardia intestinalis
(also known as G. duodenalis), Dientamoeba fragilis and Entamoeba
histolytica these protozoa contribute to a variety of acute, persistent
and chronic gastrointestinal illnesses in immune-competent per-
sons.3,5,6 Protozoan related morbidity and mortality in humans world-
wide is well documented. However, little attention has been paid to
human infections in developed countries, where the risk of transmis-
sion is assumed to be low.2,7 Several species of enteric protozoa exist
in Australia, with some being endemic. In (the State of) New South
Wales, Australia, infectious disease surveillance captures only two pro-
tozoan infections: giardiasis and cryptosporidiosis. Once a diagnosis
has been confirmed, public health units must be notified to take pre-
ventative actions.8 Pathogenic protozoa such as Cyclospora and
Entamoeba histolytica are less prevalent, being usually associated with
travel to developing regions.5,9
Blastocystis spp. is the most common protozoan diagnosed in devel-
oped countries, although its role in eliciting gastrointestinal pathology
and symptoms remain uncertain and controversial.10,11 Clinical fea-
tures of illness which have been attributed to Blastocystis spp. include
nausea, anorexia, abdominal pain, flatulence and acute or chronic
diarrhoea.7,10,11 It is often associated with chronic gastrointestinal ill-
ness of unknown aetiology and with irritable bowel syndrome (IBS)-
like symptoms.7,12 Some clinicians consider the identification of
Blastocystis from patient stools only as a potential marker of exposure
Significance for public health
This research is significant since it provides the most recent epidemiologi-
cal update on the common enteric protozoa affecting Australians. It reveals
that enteric protozoa cause considerable disease burden in high risk city
dwellers, and provides the evidence base for development of targeted inter-
ventions for their prevention and control in high risk populations. The preva-
lence of enteric protozoa in this metropolitan setting underscores that
microorganisms do not respect borders and that a collaborative approach is
needed to contain the global spread of infectious diseases. Incorporating
spatial analysis is valuable in providing a compelling picture of the geo-
graphical distribution of these often neglected diseases. Local and State
Public Health departments can use this information to support further inves-
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to faecal contamination and not necessarily the cause of specific
pathology.13
Cryptosporidium spp., accounts for about 20% of diarrhoeal
episodes in children in developing countries, but <9% in developed
settings.14 Infections are usually characterised by self-limiting diar-
rhoea associated with severe abdominal pain in immunosuppressed
and immunocompetent persons, especially those HIV-infected and
children worldwide.3,6 In developed countries transmission occurs
from person-to-person, especially in day care settings and between
men who have sex with men (MSM), as well as through water borne
and zoonotic infections.6,15
Cyclospora cayetanensis has emerged as an important cause of
endemic or epidemic diarrhoeal illness in children and adults world-
wide. Clinical illness is characterised by persistent diarrhoea, bloating,
flatulence, abdominal cramps, constipation, and fatigue.6
Cycloisosporiasis is a common cause of illness amongst returned inter-
national travellers,5,9 although non-travel and water-borne related
cases and food-borne outbreaks have been reported in developed coun-
tries.16,17 The pathogenicity of Dientamoeba fragilis has been widely
debated.3,18 Infection can be acute or chronic, and symptomatic
patients exhibit abdominal pain, persistent diarrhoea, loss of appetite,
weight loss and flatulence, as well as IBS like symptoms.18 Studies have
found D. fragilis to be of similar or greater prevalence when compared
with Giardia.7
Giardiasis, caused by the protozoon Giardia intestinalis (aka G. lam-
blia), has been reported in both animals and humans, being particular-
ly common in infants, young children and young adults. Symptoms
include diarrhoea, stomach cramps, bloating, nausea, fatigue, and if
chronic, weight loss.19 The faecal-oral route is the most important
mode of infection, and various studies have found evidence of zoonot-
ic transmission.20 In Australia giardiasis is frequently associated with
waterborne infections, day care centre disease outbreaks, and travel-
associated diarrhoea.21
Protozoa are often found as co-infections with enteric bacteria and
other parasites, particularly in developing settings and in out-
breaks.22,23 Co-infection with multiple pathogens is usually an indica-
tion of exposure to sources contaminated with animal and or human
excreta through a variety of routes.24,25
Geographical information systems (GIS) have emerged as important
tools to improve quantification and understanding of spatial variation
in disease risk and spread.26 Disease maps are useful tools for under-
standing the distribution of the disease incidence, identification of
underlying geographical risk factors, and enabling rapid decision mak-
ing and response for the containment, management and eradication of
infectious diseases.27 However, very few studies have incorporated spa-
tial tools for enteric protozoa, with little or no evidence of this from
Australia. Geographical, environmental and other socio-cultural differ-
ences among the populations across Sydney, may impact on the distri-
bution of cases of enteric protozoan infections. However no scientific
assessment or epidemiological studies of the prevalence of enteric pro-
tozoa and their geographical distribution has been done in Australia.
The aim of this study was to provide a detailed description of i) the
epidemiology and ii) geographical distribution of enteric protozoa
infections in the Greater Sydney Metropolitan Area. Laboratory and
clinical data were used to describe the demographic and clinical fea-
tures and to map the geographical distribution of enteric protozoa
detected in patients seen at four major public hospitals in Sydney:
Liverpool Hospital (Hospital A); Children’s Hospital at Westmead
(Hospital B); St. Vincent’s Hospital, Sydney (Hospital C); Prince of
Wales Hospital (Hospital D). Symptomatic patients seen in these hos-
pitals come from across the Sydney Region, including persons within
the Sydney metropolitan area as well as cases referred to these hospi-
tals from all over the State of New South Wales (NSW). The NSW Public
Health Services, divided into eight rural and metropolitan Area Health
Services, have responsibility for hospitals, clinics, community health
centres and support programs in their respective area. Four hospitals
located in Metropolitan Sydney, including two of thirteen principal
referral hospitals for adults, one major public hospital and the largest
stand-alone paediatrics hospital State-wide, were included in this
study. Hospitals A and D captured both adults and children; Hospital B
captured paediatric cases state-wide and only adult cases (≥15 years)
were included from Hospital C. Clinical laboratories within all four
Hospitals provide laboratory services for smaller hospitals within their
respective Area Health Service, and for some rural health services in
the Newcastle, Illawarra and Hunter regions and therefore captures a
wide cross section of the NSW State population. Hence the data linked
to patent’s illness histories should reflect an unbiased picture of the
distribution of cases across NSW State. In asymptomatic protozoan
infections, the likelihood of patients reporting to hospitals is low, and
reporting to hospital for a microbiological test would be strongly influ-
enced by the location of the hospitals, and whether or not testing facil-
ities are conveniently located in relation to their daily activities.
Obtaining clinical information from comparable asymptomatic cases
and or a control group proved difficult in this setting, and hence only
symptomatic cases were analysed and discussed in this study. The data
represents cases seen over the period 2007-2010.
Design and methods
Ethical approval for this study was received from the Human
Research Ethics Committees (HREC) for each of the four Hospitals,
and the University of Technology, Sydney (UTS) and was guided by the
Australian National Statement on Ethical Conduct of Research involv-
ing humans. The data presented represent a subset of data from a larg-
er study investigating the prevalence of gastrointestinal pathogens in
patients seeking care in Sydney. Laboratory and clinical records were
identified for all persons who had a stool specimen positive for enteric
protozoa over the period January 2007 − December 2010. Of the 25,914
stool specimen tested for enteric protozoa, there were 910 individual
cases positive for one or more enteric protozoa across the four centres.
Hospital ethical guidelines prohibited the collection of personal identi-
fiers, excepting for postal code of the patients’ residences. The postal
code of residence for each patient was sourced for 580 cases, and was
Article
Table 1. Distribution of specimen tested and proportion of cases positive reviewed in the four study sites.
Hospital laboratory Stool specimen tested Positive for protozoa Medical records reviewed 
% (n) % (n)
Hospital A 2138 8.8 (187) 46 (85)
Hospital B 10,123 1.2 (118) 67 (81)
Hospital C 7575 6.9 (525) 13 (70)
Hospital D 6078 1.3 (80) 20 (16)
Total 25,914 3.5 (910) 27.7 (252)
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used as the spatial location identifier for cases. 
The patients were classified based on gender, age group and species
of protozoa. To provide an epidemiological picture of protozoan infec-
tions in Sydney, we reviewed the clinical data for a subset of 252 cases
(28% of 910 positive cases) who presented with watery, liquid or loose
stool specimens. These include 85 (34%) from Hospital A; 81 (32%)
cases from Hospital B; 70 (28%) from Hospital C; and 16 (6%) from
Hospital D as presented in Table 1. Microbiological methods 
Laboratory diagnoses were performed using standard quality con-
trolled procedures in the National Association of Testing Authorities,
Australia (NATA) accredited laboratories at the four Sydney Hospitals.
Each laboratory tested on average one stool sample per patient using
microbiological procedures previously described.28,29
All hospitals routinely tested for both viral and bacteriological
pathogens when patients present with gastrointestinal symptoms.
Bacteriology and virology studies were done on stool specimen using
standard methods.Parasitology 
All hospitals processed stools by a wet preparation in saline, and
examined for white blood cells, red blood cells and cysts, ova and para-
sites (COP).30,31 Direct microscopy was routinely performed on all stool
specimens for the detection of COP, and concentration techniques per-
formed on request at Hospitals A, B and D, and routinely at Hospital C.
In order to detect COP, an aliquot of faeces was emulsified in sodium
acetate acetic acid formalin (SAF) fixative and processed for perma-
nent staining by modified iron haematoxylin staining technique (to
identify cysts and trophozoites)28 and formal ethyl acetate concentra-
tion (for the identification of helminths and ova).32
Specifically, when a COP test was requested and if any parasites
were seen in the wet preparation, a sample of stool was placed into SAF
fixative (Oxoid, Australia) using a 1:5 ratio and processed for faecal
concentration and stained using the Faecal Parasite Concentrator
(FPC) (Evergreen Scientific, LA, CA, USA) which uses centrifugation at
500 g ×10 minutes and examined for COP using oil immersion
(Hospital B). If the specimen was not received in SAF (Hospitals A and
D only), then an enzyme immunoassay (EIA) screen was performed for
the detection of Giardia/Cryptosporidium (ProSpecT™
Giardia/Cryptosporidium Microplate Assay) and Entamoeba histolyti-
ca/dispar (ProSpecT™ Entamoeba histolytica, Remel). A 10% suspen-
sion of stool was prepared in 10% formalin (for G. intestinalis and
Cryptosporidium) and the EIA was performed in accordance with the
manufacturer’s instructions and without modification. All positive EIA
findings were confirmed by microscopy (i.e. iodine preparation and
acid fast stain). Cryptosporidium smear was alternatively done using a
Modified Kinyoun’s Acid-Fast Stain (Cold) at Hospital B. In some cases,
the fixed smear was prepared for permanent staining by iron haema-
toxylin staining (IHS) with modified acid fast stain (Hospitals A and
C). Additionally at Hospital C, the wet preparation was examined under
a low power objective (10×) and then scanned under the high dry
(40×) objective. All stool specimens were emulsified in SAF fixative
(Oxoid Australia) using a 1:3 ratio, then was centrifuged at 500 g for 10
minutes. Samples were then processed for permanent staining by a
modified iron haematoxylin staining (mIHS) technique incorporating
a carbol fuschin step to stain for acid fast organisms (Isospora,
Cryptosporidium and Cyclospora).28 Polymerase chain reaction (PCR)
was employed where stool samples underwent direct DNA extraction
using a QIAamP DNA stool minikit (Qiagen, Hilden, Germany) using a
portion of fresh stools sample for the identification of Entamoeba spp.
These methods have been previously described by Stark and col-
leagues.31,33,34
Data description and analysis
While some of the hospitals employed different testing algorithms,
all hospitals used accredited standard, quality controlled procedures for
the detection of enteric protozoa. We thus considered that merging of
the data from the four hospitals into a single database was reasonably
justified in order to explore the geographic distribution and epidemio-
logical history of the patients. Going forward therefore, the data are
analysed and discussed without further distinction in regards to the
hospitals in which they were generated. 
The results of the microbiology tests were de-identified and entered
in a database including: post-code of residence of patient; age; gender;
species of protozoa diagnosed.
Frequencies and means of basic demographic, clinical and laborato-
ry findings for cases were described. Pearson’s chi-squared (χ2) analy-
sis and Spearman correlation (r) were used for correlation analysis test
associations between non-parametric relationships. The associations
between protozoa detected and gender, age, symptoms and post code of
residence were examined by binary logistic regression analysis to cal-
culate odds ratios and 95% confidence intervals. Blastocystis was
selected as the reference protozoan as it was the most common proto-
zoan detected and not routinely considered as pathogenic. Hospital C
was selected as the reference facility because it tested for all protozoan
species. The 0-5 age group was selected as the reference age group for
convenience and Sydney region was selected as the reference region,
as the majority of cases came from there. All post codes were catego-
rized based on districts in New South Wales (NSW) (http://www.home-
help4u.net/postcode_tool/postcode_list_NSW.php), and the districts
were listed in ascending order based on the grouping of post codes. The
IBM SPSS Statistic version 19 (SPSS Inc. Chicago, IL, USA) was used
for data analysis. 
To display and analyse the geographic distribution of the patients as
a base map of the Australian postal areas (POA) 2006 Digital
Boundaries (ESRI shape file) from the Australian Bureau of Statistics
archive (http://www.abs.gov.au/) was used. The commercial software
ArcGIS Desktop (version 9.3) was used to extract the postcodes for the
state of NSW, and joined by the postcode fields to the hospital data to
generate a table of attributes for the extracted layer. We queried this
layer to produce derivative layers of the distribution of individual para-
sites across the state by Postcode. The derivative layers were then used
to construct the maps shown in Figures 1 and 2.
ResultsClinical and epidemiological profile
The demographic and clinical features of cases are presented in
Table 2. There appears to be no identifiable distinction between gen-
ders in the incidence of pathogens. However in the 25-75 years age
groups there were more males than females [χ2(df) 11.5(4); P=0.04]
(Figure 3). A bimodal age distribution was observed with the preva-
lence of protozoa decreasing with age in the 24 years and under age
group, and increasing with age in the over 25 years age groups. Watery
diarrhoea (82%), abdominal pain (48%) and vomiting (45%) were the
most frequent symptoms reported by patients presenting at each hospi-
tal (Table 2). 
The age specific distribution of the cases based on clinical symptoms
and protozoa detected is presented in Table 3. Vomiting [χ2=15.6(4);
P=0.004] and fever [χ2=14.2(4); P=0.007] were more common in
younger patients, compared with nausea in older persons [χ2=32.9(4);
P=0.001]. 
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Figure 1. Map of New South Wales showing distribution of cases affected by the five enteric protozoa Blastocystis (A), Giardia (B),
Cryptosporidium (C), Dientamoeba (D), and Cyclospora (E). Note the change of scale in (F) zooming in on Cyclospora cases in Sydney
City Business District.
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Enteric protozoa were identified in an average of 4% (95%CI 1.1-
11.2%) of 980 specimens which tested positive from all hospitals.
Overall, the most common enteric protozoa detected were Blastocystis
spp., in 5% (95%CI 5-6%) of cases, followed by G. intestinalis (1%;
95%CI 1-1.2%), D. fragilis (1%, 95%CI 0.7-1%) and E. histolytica/dispar
in 0.5% (95%CI 0.4-0.6%). On average, between 1% and 9% of cases
from each hospital were infected with enteric protozoa (Table 1). Of the
580 cases included in the review, a co-infecting organism was reported
in 23% (132); including infectious bacteria in 30% (39), pathogenic
protozoa (including Blastocystis spp.) in 39% (52), non-pathogenic pro-
tozoa in 24% (31) and enteric viruses in 7% (9) (data not shown).
Amongst cases with gastrointestinal symptoms Blastocystis spp. (61%),
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Figure 2. Distribution of cases of protozoa, and location of co-infections with Blastocystis spp and infectious protozoa, based on New
South Wales Post Codes. The map illustrates (A) the total protozoa detected across the State from four hospitals; (B) where pathogen-
ic protozoa cases overlap with cases of Blastocystis infection. Note change of scale in (C) showing a zooming in on dense cases in the
Sydney City Business District. 
Figure 3. Distribution of protozoa cases based on age and gender (A), age groups (B), and gender and protozoa detected (C). Numbers
in brackets represent the number of cases in each category. There were co-infections with two or more protozoa in some cases.
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Table 2. Demographic and clinical characteristics of diarrhoeal cases by Hospitals.
Characteristic Hospital A, % (n) Hospital B, % (n) Hospital C, % (n) Hospital D, % (n) Total % (n)
Age group, years
0-5 3.5 (3) 43.2 (35) 0 (0) 56.3 (9) 18.7 (47)
6-12 5.9 (5) 38.3 (31) 0 (0) 12.5 (2) 15.1 (38)
13-24 3.5 (3) 18.5 (15) 8.6 (6) 0 (0) 9.5 (24)
25-49 34.1 (29) 0 (0) 48.6 (34) 25.0 (4) 26.6 (67)
50-75 52.9 (45) 0 (0) 42.9 (30) 6.25 (1) 30.2 (76)
Gender
Male 52.9 (45) 50.6 (41) 71.4 (50) 56.3 (9) 57.5 (145)
Female 47.1 (40) 49.4 (40) 28.6 (20) 43.8 (7) 42.5 (107)
Symptoms 
Diarrhoea 73.8 (62) 82.7 (67) 95.7 (67) 62.5 (10) 82.1 (206)
Vomiting 44.0 (37) 61.7 (50) 28.6 (20) 50.0 (8) 45.8 (115)
Nausea 35.7 (30) 9.9 (8) 44.3 (31) 12.5 (2) 28.3 (71)
Abdominal pain 57.1 (48) 44.4 (36) 44.3 (31) 31.3 (5) 47.8 (120)
Fever 29.8 (25) 48.1 (39) 25.7 (18) 3.5 (6) 35.1 (88)
Dehydration 15.5 (13) 13.6 (11) 8.6 (6) 31.3 (5) 13.9 (35)
Anorexia/loss of appetite 15.3 (13) 24.7 (20) 7.1 (5) 6.3 (1) 15.5 (39)
Lethargy 14.1 (12) 28.4 (23) 11.4 (8) 18.8 (3) 18.3 (46)
Respiratory symptoms 3.6 (3) 17.3 (14) 1.4 (1) 12.5 (2) 8.0 (20)
Total per hospitals 33.7 (85) 32.1 (81) 27.8 (70) 6.4 (16) 100.0 (252)
Variables coded as dichotomous variable with:  diarrhoea, vomiting, nausea, abdominal pain, fever, and dehydration- each coded as No=0, Yes=1; Anorexia, lethargy, and respiratory symptoms each coded as No=1,
Yes=2; Blastocystis: No=1, Yes=2; Cryptosporidium: No=1, Yes=2; Dientamoeba fragilis: No=1, Yes=2; Entamoeba species: No=1, Yes=2; Giardia: No=1, Yes=2.
Table 3. Age specific distribution of cases based on demographic, clinical signs and protozoa detected.
Responses 0-5 yrs 6-12 yrs 13-24 yrs 25-49 yrs 50-75 yrs % total cases (n) χ2 (df); P value
Female 10.3 (26) 7.5 (19) 5.2 (13) 34.3 (23) 10.3 (26) 42.5 (107)
Male 8.3 (21) 7.5 (19) 4.4 (11) 17.5 (44) 19.8 (50) 57.5 (145) 9.34 (4); 0.053
Diarrhoea 80.9 (38) 76.3 (29) 91.7 (22) 77.6 (52) 86.7 (65) 82.1 (206) 4.39 (4); 0.356
Vomiting 66.0 (31) 50.0 (19) 58.3 (14) 32.8 (22) 38.7 (29) 45.8 (115) 15.56 (4); 0.004
Fever 51.1 (24) 47.4 (18) 33.3 (8) 32.8 (22) 21.3 (16) 35.1 (88) 14.20 (4); 0.007
Abdominal pain 14.9 (7) 71.1 (27) 66.7 (16) 62.7 (42) 37.3 (28) 47.8 (120) 41.30 (4); 0.001
Dehydration 14.9 (7) 7.9 (3) 20.8 (5) 13.4 (9) 14.7 (11) 13.9 (35) 2.19 (4); 0.701
Lethargy 34.0 (16) 18.4 (7) 20.8 (5) 16.4 (11) 9.2 (7) 18.3 (46) 12.28 (4); 0.015
Anorexia 23.4 (11) 23.7 (9) 25.0 (6) 7.5 (5) 10.5 (8) 15.5 (39) 10.59 (4); 0.032
Respiratory symptoms 21.3 (10) 13.2 (5) 4.2 (1) 1.5 (1) 4.0 (3) 8.0 (20) 18.66 (4); 0.001
Nausea 2.1 (1) 10.5 (4) 41.7 (10) 41.8 (28) 37.3 (28) 28.3 (71) 32.93 (4); 0.001
Blastocystis spp. 5.9 (9) 9.8 (15) 11.1 (17) 31.4 (48) 41.8 (64) 61.0 (153) 62.46 4; 0.001
Giardia 45.5 (25) 23.6 (13) 1.8 (1) 16.4 (9) 12.7 (7) 21.9 (55) 45.05 (4); 0.001
Dientamoeba fragilis 18.8 (6) 21.9 (7) 28.1 (9) 9.4 (3) 21.9 (7) 12.7 (32) 19.46 (4); 0.001
Cryptosporidium spp. 44.4 (8) 16.7 (3) 5.6 (1) 27.8 (5) 5.6 (1) 7.2 (18) 11.15 (4); 0.025
Entamoeba spp. 11.1 (1) 0 (0) 0 (0) 66.7 (6) 22.2 (2) 3.6 (9) 8.35 (4); 0.080
Pearson’s Chi squared test: diarrhoea vomiting, nausea, abdominal pain, fever, and dehydration, each coded as dichotomous variable with No=0, Yes=1; Anorexia, lethargy, and respiratory symptoms each coded as
No=1, Yes=2; Blastocystis: No=1, Yes=2; Cryptosporidium: No=1, Yes=2; Dientamoeba fragilis: No=1, Yes=2; Entamoeba species: No=1, Yes=2; Giardia: No=1, Yes=2.
Giardia intestinalis (22%), Dientamoeba fragilis (13%),
Cryptosporidium spp. (7%), and Entamoeba spp. (4%) were frequently
detected. The incidence of Blastocystis spp., increased with age, with
persons over 50 years of age having the highest incidence, compared
with higher incidence of Cryptosporidium spp. [χ2=11.2(4); P=0.025]
and Giardia in the under 13 years age groups [χ2=45.1(4); P=0.001].
The incidence of Dientamoeba fragilis also increased with age, and was
mainly evident in the under-25 age groups [χ2=19.5(4); P=0.001].
Diarrhoea was reported by the majority of persons infected with D.
fragilis (91%), Cryptosporidium spp. (88%), Giardia (82%) and
Blastocystis spp. (81%). Vomiting was significantly associated with
Giardia intestinalis infection [58%; χ2=4.5 (1); P=0.046]. Several of
the cases (30/250) reported overseas travel in the past 6 weeks, with
50% being to Asia (mainly the Indian sub-continent), 23% to South
Pacific Islands, 13% to Africa and two each to Europe and North
America (data not shown).
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Spatial distribution 
The post-code distribution of patients is shown in Figure 1. Some
interesting patterns emerge. Infection with Blastocystis spp., the most
commonly detected protozoa, was focused in the Metropolitan Area,
with additional clusters in the Southern Coast and Hunter New
England Area. The distribution of G. intestinalis had some overlaps with
Blastocystis spp., except that additional cases were also identified in
the Central Tablelands, North West and Murray regions. Dientamoeba
fragilis, Cryptosporidium spp., and Entamoeba spp., had a less wide dis-
tribution.
Based on its high prevalence in the population and controversy sur-
rounding the pathogenicity of Blastocystis spp., the distribution of the
other known pathogenic protozoa in relation to the distribution of
Blastocystis spp. was further examined. Figure 2 illustrates the distri-
bution of four known pathogenic protozoa: G. intestinalis,
Cryptosporidium spp., D. fragilis, and Cyclospora, in areas where infec-
tions coincided with infections with Blastocystis spp. The figure shows
that overlaps in the distribution of cases were mainly distributed
around the Sydney Metropolitan Area, with other clusters identified in
the Hunter New England Health Area [Post Code 2400 (4 Giardia and 7
Blastocystis from 11 cases); and Post Code 2347 (2 Giardia and 1
Blastocystis from 2 cases)] and the Southern Coast: [two cases identi-
fied in PC 2540 (Blastocystis and G. intestinalis), two in 2535
(Blastocystis and D. fragilis) and two in PC 2579 (Blastocystis and D.
fragilis)]. There was less overlap in the distribution of protozoa in the
Western, Southern and Northern areas of the State, and a few cases
scattered in hinterland areas. 
An examination of the relationships between different protozoa
revealed that there was a weak positive correlation between region of
residence and infection with Giardia intestinalis (0.148; P=0.001) and
a weak negative relationship with Blastocystis (−0.130; P=0.002).
While not statistically unequivocal, the evidence suggests that future
studies should set out to test the possibility that infection with Giardia
intestinalis may be more common in persons living further away from
the Sydney City Business District (CBD), compared with Blastocystis
infections having a stronger association with living close to or within
the CBD. A closer look at the relationship between these two protozoa
reinforces this interpretation, because there is a strong negative rela-
tionship between the distribution of G. intestinalis and Blastocystis
(Spearman’s R: −0.545; P=0.0001). This suggests that there were sig-
nificantly more cases of Blastocystis infections in areas where Giardia
intestinalis infections were absent. No other significant relationships
were observed in the distribution of the other enteric protozoa. 
Discussion
This multi-centre study presents the first detailed description of i)
the epidemiology and ii) geographical distribution analysis of patients
with gastrointestinal symptoms and infected with enteric protozoa in
New South Wales, Australia. The study found that enteric protozoa
prevalence is age related and there is a possible association between
the prevalence of individual protozoan species and geographic distribu-
tion of cases. 
The age distribution of enteric protozoa reveals that in this popula-
tion, persons under 13 years old had a higher incidence of infection
with Cryptosporidium spp. and Giardia. These infections in younger
children are consistent with current knowledge, especially since those
in the under-five age group have poorly developed hygiene habits and
are more susceptible to enteric infections 35
Both Cryptosporidium spp. and Giardia are considered to be neglect-
ed tropical diseases (NTDs), infections commonly affecting the world’s
poorest people, including the bottom billion, (approximately 1.4 billion
people living on no money), who are affected by one or more NTDs.36
These diseases result in high levels of global disability and destabiliza-
tion of communities and tend to trap people in poverty through their
adverse effects such as the impairment of child development, pregnan-
cy outcomes, reduced agricultural productivity and food security.36
Infections with NTDs in Australia can disproportionately affect indige-
nous populations,37 however infections such as giardiasis and cryp-
tosporidiosis have been reported amongst non-Aboriginal urban
dwellers in outbreak and non-outbreak settings.15,37
Nearly one in every five protozoa detected had a co-infecting organ-
ism, with the majority of co-infections being with either pathogenic
protozoa (39%) or infectious enteric bacteria (30%). Co-infection with
multiple parasites is not uncommon and has been widely found and is
likely an indication of transmission via the faecal oral route through
contaminated food or water or other unhygienic practices.7,22,23
A specific trend was observed for the 25-49 years age group around
the Sydney Central Business District (CBD) (R=0.09; P=0.025). In this
location, more men were infected with protozoa than women, against a
general state-wide statistics in which no observable large scale differ-
ence between genders was observed. We suggest that this may be due
to the presence of a high risk population of MSM residing in and seek-
ing care in the CBD. Data on MSM status was unavailable for some hos-
pitals, although previous studies showed 52% of stool specimens from
MSM were positive for protozoa compared with 13% from non-MSM.15
The relatively high prevalence of Blastocystis spp. is not surprising
considering its ubiquitous nature and usual high prevalence.7,15 It is
interesting that all clinical laboratories involved in this study routinely
test for this protozoan, and despite controversies about its role as a
pathogen, it is usually used as a marker/indicator of exposure to faecal
contamination, and can raise enough suspicion to look for other recog-
nized pathogens. More than 10% of cases reported overseas travel −
mainly to Asia, which is a major risk factor, and important indicator for
protozoan infection monitoring in developed settings.5,9,38
Sufficient data was unavailable to explain the incidence of Giardia
infections in the Southern Coast and Hunter New England areas. It is
possible that these are linked to environmental sources of infection
(water, sewage), but further investigations in these areas is warranted
to establish conclusively the causes of infection and to suggest possi-
ble control strategies. However, that the data reveals an increase in the
cases of Giardia over the March to May period (Southern hemisphere
autumn) during the four year period of 2008-2012, which was consis-
tent with State infectious disease surveillance data for this period.39 In
addition, the NSW State Bureau of Meteorology reported that in 2010,
NSW  experienced the wettest autumn since 2000, and, north-western
NSW rivers were awash with floodwaters, following torrential rain in
Queensland, during early March 2010. Furthermore, an East Coast Low
brought heavy rainfall to most southern regions at the end of May
2010.40 These phenomena could have resulted in contamination of
drinking water supplies in the affected areas. The affected areas would
include the Southern Coast and Hunter New England areas where the
clustering of cases outside of the CBD has been observed. A Brazilian
study however, found no associations between Giardiasis and season-
ality or rainfall.41 In the absence of a clear explanation for the cases of
giardiasis reported from these areas, there is a need for further stud-
ies to understand the relationships observed. 
A 2004 report indicated that Giardiasis is a major public health prob-
lem in the New England Area, and may be associated with drinking
water from rain-water tanks.42 The report indicated that these infec-
tions occurred in an area in close proximity to Aboriginal (indigenous)
settlements. Giardiasis infections among Aboriginal communities are
considered to be common especially in children under five years of
age.43 However, the Aboriginal status of these cases could not be ascer-
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tained. If communities in these regional areas of Sydney are faced with
increased risk of giardiasis infections, there is therefore need for rural
hospitals to have the diagnostic capacity for the timely diagnosis of
enteric protozoa. In addition, water authorities should ensure frequent
monitoring of water quality for enteric protozoa. 
The study also revealed that infections with G. intestinalis were more
likely to be detected in persons who were not infected with Blastocystis.
This could be an indication that Blastocystis spp. were in fact the actual
cause of gastrointestinal symptoms or that patients were infected with
enteric pathogens that were not detected by microbiological tests. Wet
preparation and concentrates are routinely used in majority of hospitals
to detect Blastocystis spp., but have limited sensitivity compared with
microscopy of fixed, permanently stained (modified iron-haematoxylin,
trichrome staining) smears for the detection of some protozoa.28 Antigen
detection by immunoassays44,45 and PCR have demonstrated higher sen-
sitivities when compared with microscopy and permanent staining, but
are more costly and not widely used in this setting.12,28,31 The submission
of (up to three) repeat stool specimen at daily intervals has been widely
considered standard for improved detection of enteric protozoa, due to
intermittent shedding of trophozoites in stool,28,46 but compliance with
the submission of repeats specimen is not consistently done in Sydney
and is often not realistic owing to the distances people need to travel to
health facilities for diagnostic tests. Hence the use of retrospective data
to identify possible geographic trends is valuable for the development of
public health preventative measures that are likely to have more long
term impact in managing protozoan infection risk, than the testing pro-
cedures for sick patients.
Whilst this study did not set out to investigate antimicrobial sensitivi-
ty patterns for common enteric protozoa, clinical and in vitro studies con-
ducted by other members of this research cluster have revealed increas-
ing ineffectiveness of commonly recommended antiprotozoal compounds
against Dientamoeba fragilis, including Iodoquinol, Paromomycin, and
Tetracycline.34,47 Treatment failure and resistance to Metronidazole and
Iodoquinol has been increasingly being reported amongst Blastocystis
spp.48,49 Newer antiprotozoal compounds, such as 5-nitroimidazoles,
ornidazole and ronidazole which are believed to have fewer adverse
effects on the patient, have proven to be more effective in treating D.
fragilis in vitro and should be considered as suitable alternatives to cur-
rent drugs. Further studies are needed to determine the level of antipro-
tozoal resistance amongst common infectious enteric protozoa at the
community level.
Conclusions
There are no current national or state-wide estimates which describe
the epidemiology of enteric protozoa in Australia. This is the first study
to incorporate geographic analysis to define the epidemiology of enteric
protozoa in New South Wales State, since the last 20 years. The findings
suggest a widespread distribution of several infectious protozoa and
indicate the need for further studies to estimate the prevalence and bur-
den of enteric protozoa infections at a national level. Understanding the
geographical distribution of patients diagnosed with enteric protozoan
infections is beneficial for identifying areas with unusually high rates,
early detection of outbreaks, and informing planning and implementa-
tion of public health interventions. This information is also useful to
inform the public of where potential risks may exist so they can take the
necessary precautions, such as attending to hand and personal hygiene
and the boiling of rainwater to be used for drinking. This study has iden-
tified several enteric protozoa species with substantial prevalence in
Sydney, with the very young and aging persons being more susceptible to
infection. This highlights the need for public health interventions such
as hand and personal hygiene messages to be reiterated especially
amongst school age children and aged care settings. Spatial distribution
suggests that underlying behavioural and geographical risk factors may
be driving the prevalence in some areas. Further investigation needed to
determine these risk factors. The findings of this study can provide use-
ful information for policy makers to design and where possible, tailor
interventions to target high risk communities. 
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